Atherogenic lipoproteins stimulate mesangial cell p42 mitogen-activated protein kinase

Journal of the American Society of Nephrology

Volumn 9, Issue 3, 1998, Pages 488-496

  Bassa, Babu V ^b   Roh, Daeyoung D ^b   Kirschenbaum, Michael A ^b   Kamanna, Vaijinath S ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; KIDNEY INJURY; LIPOPROTEIN METABOLISM; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031912445     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 39: S41-S48, 1991
2. Kamanna VS, Kirschenbaum MA: Association between very low density lipoprotein and glomerular injury in obese Zucker rats. Am J Nephrol 13: 53-58, 1993
3. Avram MM: Similarities between glomerulosclerosis and atherosclerosis in human renal biopsy specimens: A role for lipoprotein glomerulopathy. Am J Med 87: 39N-41N, 1989
4. Lee HS, Lee JS, Koh HI, Ko KW: Intraglomerular lipid deposition in routine biopsies. Clin Nephrol 36: 67-75, 1991
5. Wheeler DC, Chan RS, Topley N, Petersen MM, Davies M, Williams JD: Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 45: 1628-1636, 1994
6. Keane WF, O'Donnell MP, Kasiske BL, Kim Y: Oxidative modification of low density lipoproteins by mesangial cells. J Am Soc Nephrol 4: 187-194, 1993
7. Kamanna VS, Bassa BV, Kirschenbaum MA: Atherogenic lipoproteins and human disease: Extending concepts beyond the heart to the kidney. Curr Opin Nephrol Hypertens 6: 205-211, 1997
8. Berliner JA, Territo MC, Sevanian A, Rammin S, Kim JA, Bamshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial cell interaction. J Clin Invest 85: 1260-1266, 1990
9. Kamanna VS, Pai R, Roh DD, Kirschenbaum MA: Oxidative modification of low density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration and proliferation. Lab Invest 74: 1067-1079, 1996
10. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM: Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 87: 2253-2257, 1991
11. Magil AB, Frohlich JJ, Innis SM, Steinbrecher WP: Oxidized low density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43: 1243-1250, 1993
12. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57: 10-15, 1991
13. Dasgupta A, Hussain S, Ahmad S: Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 60: 56-59, 1992
14. Ha H, Pai R, Kamanna VS, Kirschenbaum MA: Oxidatively modified LDL stimulates monocyte adhesion to glomerular endothelial cells mediated by ICAM-1. J Am Soc Nephrol 6: 830A, 1995
15. Pai R, Kirschenbaum MA, Kamanna VS: Low density lipoprotein stimulates the expression of macrophage colony stimulating factor in glomerular mesangial cells. Kidney Int 48: 1254-1262, 1995
16. Kamanna VS, Roh DD, Kirschenbaum MA: Atherogenic lipoproteins mediators of glomerular injury. Am J Nephrol 13: 1-5, 1993
17. Rovin BH, Tan LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43: 218-225, 1993
18. Grone EF, Abboud HE, Hohne M, Walli AK, Grone HJ, Stuker D, Robenek H, Wieland E, Seidel D: Actions of lipoproteins in cultured human mesangial cells: Modulation by mitogenic vasoconstrictors. Am J Physiol 263: F686-F696, 1992
19. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81: 3883-3887, 1984
20. Yokoyama M, Hirata K-I, Miyake R, Akita H, Ishikawa Y, Fukuzaki H: Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun 168: 301-308, 1990
21. Chen L, Liang B, Froese DE, Liu S, Wong JT, Tram K, Hatch GM, Mymin D, Kroeger EA, Man RYK, Choy PC: Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: Effect of lysophosphatidylcholine composition on vascular relaxation. J Lipid Res 38: 546-553, 1997
22. Jougasaki M, Kugiyama K, Saito Y, Nakao K, Imura H, Yasue H: Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ Res 71: 614-619, 1992
23. Liu S-Y, Lu X, Choy S, Dembinski TC, Hatch GM, Mymin D, Shen X, Angel A, Choy PC, Man RYK: Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: Relationship to endothelium dependent relaxation. Cardiovasc Res 28: 1476-1481, 1994
24. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 344: 160-162, 1990
25. Murugesan G, Fox PL: Role of lysophosphatidylcholine in the inhibition of endothelial cell mobility by oxidized low density lipoprotein. J Clin Invest 97: 2736-2744, 1996
26. Scott-Burden T, Resink TJ, Hahn AWA, Bauer U, Box RJ, Buhler FR: Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoproteins. J Biol Chem 264: 12582-12589, 1989
27. Resink TJ, Tkachuk VA, Bernhardt J, Buhler FR: Oxidized low density lipoprotein stimulates phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler Thromb 12: 278-285, 1992
28. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92: 471-478, 1993
29. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993
30. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
31. 3H1 myocytes by fluoroaluminate. J Biol Chem 266: 10131-10135, 1991
32. Sturgill TW, Ray LB, Anderson NG, Erickson AK: Purification of mitogen-activated protein kinase from epidermal growth factor-treated 3T3-L1 fibroblasts. Methods Enzymol 200: 342-351, 1991
33. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, Striker GE: Glomerular epithelial, mesangial and endothelial cell lines from transgenic mice. Kidney Int 33: 677-684, 1988
34. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D: Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein JE/MCP-1 and the monocyte colony stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. J Clin Invest 92: 1564-1571, 1993
35. Chapman MJ: Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol 128: 70-143, 1986
36. LeBoeuf RC, Puppione DL, Schumaker VN, Lusis AJ: Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins. J Biol Chem 258: 5063-5070, 1983
37. Lusis AJ, Taylor BA, Quon D, Zollman S, LeBoeuf RC: Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J Biol Chem 262: 7594-7604, 1987
38. Lehr H-A, Krober M, Hubner C, Vajkoczy P, Menger MD, Nolte D, Kohlschutter A, Messmer K: Stimulation of leukocyte/endothelium interaction by oxidized low density lipoprotein in hairless mice: Involvement of CD11b/CD18 adhesion receptor complex. Lab Invest 68: 388-395, 1993
39. Ha H, Bassa B, Pai R, Kirschenbaum MA, Kamanna VS: Role of atherogenic lipoproteins on mesangial cell proliferation and PDGF gene expression. J Am Soc Nephrol 6: 792A, 1995
40. Wheeler DC, Persaud JW, Fernando R, Sweny P, Varghese Z, Moorhead JF: Effect of low density lipoproteins on mesangial cell growth and viability in vitro. Nephrol Dial Transplant 5: 185-191, 1990
41. Coritsidis G, Rifici V, Gupta S, Rie J, Shan Z, Neugarten J, Schlondorff D: Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 39: 858-866, 1991
42. Stiko-Rahm A, Hultgardh-Nilsson A, Regnstrom J, Hamsten A, Nilsson J: Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Thromb 12: 1099-1109, 1992
43. Kusuhara M, Chait A, Cader A, Berk BC: Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 17: 141-148, 1997
44. Bassa B, Kirschenbaum MA, Kamanna VS: Cytokine-mediated regulation of mitogen-activated protein kinase in glomerular mesangial cells. J Am Soc Nephrol 6: 783A, 1995
45. Kamanna VS, Bassa B, Kirschenbaum MA: Atherogenic lipoproteins induce mesangial cell protein tyrosine phosphorylation and activation of growth factor receptor: Signal transduction mechanisms of cell proliferation. J Am Soc Nephrol 7: 1679A, 1996
46. Guevara J Jr, Walch ET, Epstein HF, Sparrow JT, Gotto AM, Valentinova NV: Evidence that apo B-100 of low density lipoproteins is a novel Src-related protein kinase. J Protein Chem 14: 627-631, 1995
47. Bassa B, Kirschenbaum MA, Kamanna VS: Activation of mesangial cells with lysophosphatidylcholine stimulates MAP kinase: Involvement of PKC and protein tyrosine kinase. J Am Soc Nephrol 7: 1671A, 1996